NRG
MRK icon

Nemes Rush Group’s Merck MRK Stock Holding History

Nemes Rush Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6M Buy
175,548
+4,584
+3% +$537K 1.86% 15
2026
Q1 		$20.6M Sell
170,964
-11,111
-6% -$1.28M 1.95% 13
2025
Q4 		$19.2M Sell
182,075
-2,395
-1% -$225K 1.8% 14
2025
Q3 		$15.5M Buy
184,470
+1,672
+0.9% +$138K 1.53% 20
2025
Q2 		$14.5M Buy
182,798
+48,372
+36% +$3.85M 1.58% 20
2025
Q1 		$12.1M Buy
134,426
+8,587
+7% +$802K 1.52% 21
2024
Q4 		$12.5M Sell
125,839
-5,152
-4% -$531K 1.55% 18
2024
Q3 		$17.3M Sell
130,991
-6,405
-5% -$761K 2.51% 8
2024
Q2 		$17M Buy
137,396
+4,960
+4% +$639K 2.34% 10
2024
Q1 		$17.5M Buy
132,436
+12,742
+11% +$1.57M 2.5% 8
2023
Q4 		$13M Buy
119,694
+2,644
+2% +$274K 2.1% 8
2023
Q3 		$12.1M Buy
117,050
+3,002
+3% +$324K 2.18% 10
2023
Q2 		$13.2M Buy
+114,048
New +$12.9M 2.32% 9

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nemes Rush Group's MRK Position: Q2 2026 in Review

Nemes Rush Group increased its Merck (MRK) stake by 2.7% in Q2 2026, buying an estimated $537K and bringing the position to 175,548 shares worth $22.6M. The position accounts for 1.86% of the portfolio, ranked #15.

Nemes Rush Group first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Nemes Rush Group held 175,548 shares of Merck worth $22.6M as of Q2 2026.
  • Nemes Rush Group bought 4,584 Merck shares in Q2 2026, an estimated $537K.
  • Merck made up 1.86% of Nemes Rush Group's portfolio in Q2 2026, its #15 holding.
  • Nemes Rush Group first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.